Diabetes Complications Part 2Activity Description CME Release Date: April 24, 2011 CME Expiration Date: April 24, 2012 Statement of Need Because the majority of people with diabetes are cared for by their primary care providers, PCPs need a comprehensive review and update on diabetes management to provide optimal care. Advances in Diabetes, an annual CME course, initiated more than century ago by Elliott P. Joslin, MD, in conjunction with Harvard Medical School, is the longest-running continuously offered academic course in diabetes in the United States and, likely, the world. The course has evolved with diabetes practice and research as well as the changing continuing education needs of the medical profession. This Internet enduring material was developed from the following presentations by the faculty on November 11, 2010 at the Advances in Diabetes 2010 course in Boston, MA.
Target Audience This certified activity was developed for primary care providers with a practice population that includes significant numbers of people with diabetes. Learning Objectives After participating in this educational activity, healthcare professionals should be able to:
Faculty and Disclosures Julian M. Aroesty, MD Associate Clinical Professor of Medicine Harvard Medical School Staff Physician, Cardiology Beth Israel Deaconess Medical Center Boston, MA Disclosure: Dr. Julian
M. Aroesty has no relevant financial relationships
John M. Giurini, DPM Associate Professor in Surgery Harvard Medical School Chief, Division of Podiatry Beth Israel Deaconess Medical Center Boston, MA Disclosure: Dr. John
M. Giurini has no relevant financial relationships.
David R. Campbell, MD Associate Clinic Professor of Surgery Harvard Medical School Vascular Surgeon Beth Israel Deaconess Medical Center Boston, MA Disclosure: Dr. David
R. Campbell is on the speakers bureau for Cubist Pharmaceuticals, Inc., and Pfizer
Inc.
Planning Committee: Martin J. Abrahamson, MD Associate Professor of Medicine Harvard Medical School Medical Director and Senior Vice President Joslin Diabetes Center Boston, MA Dr. Martin J. Abrahamson
is on the advisory board for Halozyme Therapeutics, Merck & Co., Inc., Novo Nordisk
Inc., and sanofi-aventis U.S. LLC, and receives grant/research support from Pfizer
Inc.
Richard S. Beaser, MD Associate Clinical Professor of Medicine Harvard Medical School Medical Executive Director Professional Education Joslin Diabetes Center Dr. Richard S. Beaser,
Medical Executive Director, Professional Education, Joslin Diabetes Center, is a
consultant for CeQur Ltd.
Accreditation and Designation of Credit The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education (CME) for physicians. The Harvard Medical School designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Participants not eligible for CME credit will receive a certificate of completion. Computer Requirements To participate in this activity, your computer will need the following hardware and software: PC Users:
Macintosh Users System OS X:
Credit Instructions
Questions About This Activity For questions regarding this activity, including technical support, please contact cme@joslin.harvard.edu. To read the policy on privacy and confidentiality that relates to the CME activity, click here. |

Julien Aroesty, MD